We are live on
!
Find out more
BL
Bleichroeder LP Portfolio holdings
AUM
$559M
1-Year Est. Return
83.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.96%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$514M
AUM Growth
-$45.1M
(-8.1%)
Cap. Flow
-$126M
Cap. Flow
% of AUM
-24.6%
Top 10 Holdings %
Top 10 Hldgs %
70.54%
Holding
81
New
6
Increased
6
Reduced
6
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brunswick
BC
|
+$13.7M |
| 2 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
+$1.84M |
| 3 |
HCARU
Healthcare Services Acquisition Corporation Unit
HCARU
|
+$1.54M |
| 4 |
Sonos
SONO
|
+$1.21M |
| 5 |
Curis
CRIS
|
+$861K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$38.9M |
| 2 |
Xerox
XRX
|
+$35.4M |
| 3 |
DCP
DCP Midstream, LP
DCP
|
+$31.8M |
| 4 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$12.2M |
| 5 |
FGNA.U
FG New America Acquisition Corp. Units, each consisting of one share of Class A common stock and one
FGNA.U
|
+$5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.54% |
| 2 | Miscellaneous | 17.39% |
| 3 | Industrials | 14.37% |
| 4 | Consumer Discretionary | 11.57% |
| 5 | Materials | 9.88% |
Similar funds
NFW
IRC
SCM
PHC
EPM
BCM
FAM
WDG
Bleichroeder LP's Q4 2020 Portfolio in Review
As of Q4 2020, Bleichroeder LP held 81 positions worth $514M, down 8.1% from $559M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Bleichroeder LP withdrew a net $126M in Q4 2020, closing 9 positions and reducing 6 holdings. Its most notable exit was DCP Midstream, LP, an estimated $31.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Industrials.
Against the trend, Bleichroeder LP opened a new position in Healthcare Services Acquisition Corporation Unit worth $1.53M.
- Bleichroeder LP's largest Q4 2020 buy was Healthcare Services Acquisition Corporation Unit: 150,000 shares worth $1.53M.
- Bleichroeder LP added most to Brunswick in Q4 2020, an estimated $13.7M increase.
- Bleichroeder LP's biggest Q4 2020 reduction was Royalty Pharma, cutting an estimated $38.9M.
- Bleichroeder LP fully exited DCP Midstream, LP in Q4 2020, selling an estimated $31.8M.
- Bleichroeder LP's ten largest holdings make up 71% of its $514M portfolio in Q4 2020.
- Bleichroeder LP opened 6 new positions and closed 9 in Q4 2020.
- Bleichroeder LP's portfolio value fell 8.1% quarter-over-quarter to $514M.
Based on Bleichroeder LP's 13F filing for Q4 2020, filed 10 Feb 2021.